Back
Travere Therapeutics Vs. Neurogene Industry Stock Comparison
Sell
47
TVTX
Travere Therapeutics
Last Price:
14.3600
Seasonality Move:
-3.64%
Sell
40
NGNE
Neurogene
Last Price:
41.53
Seasonality Move:
-0.92%
Sell
47
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics a Buy, Sell or Hold?
- The current Travere Therapeutics [TVTX] share price is $14.4000. The Score for TVTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- TVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $40.27. The Score for NGNE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TVTX Stock Price Chart
What is Travere Therapeutics's stock price today?
-
The Travere Therapeutics share price today is $14.4000
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
NGNE Stock Price Chart
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 82.47 | Buy |
| Chaikin Money Flow: | 17512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.396 - 12.256) | Buy |
| Bollinger Bands (100): | (6.5589 - 10.3189) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 57.44 | Buy |
| Chaikin Money Flow: | -29871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.87 - 39.01) | Buy |
| Bollinger Bands (100): | (32.69 - 40.45) | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.96 | Buy |
| 20-day SMA: | 10.72 | Buy |
| 50-day SMA: | 9.89 | Buy |
| 200-day SMA: | 8.25 | Buy |
| 8-day EMA: | 12.93 | Buy |
| 20-day EMA: | 11.4 | Buy |
| 50-day EMA: | 10.02 | Buy |
| 200-day EMA: | 9.3 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.1 | Buy |
| 20-day SMA: | 36.84 | Buy |
| 50-day SMA: | 38.55 | Buy |
| 200-day SMA: | 33.4 | Buy |
| 8-day EMA: | 39.55 | Buy |
| 20-day EMA: | 37.91 | Buy |
| 50-day EMA: | 37.46 | Buy |
| 200-day EMA: | 33.1 | Buy |
Travere Therapeutics Earnings Growth & TVTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.36 per share, a decrease this year of $2.18 per share, and an increase next year of $2.31 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Travere Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||